| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.18B | +8.7% |
| R&D Expense | $53.1M | -7.0% |
| SG&A Expense | $304.6M | +22.2% |
| Operating Income | $471.1M | +90.0% |
| Pre-tax Income | $537.5M | +1831.7% |
| Income Tax | $163.1M | +186.4% |
| Net Income | $286.6M | +262.8% |
| EPS (Basic) | $18.75 | +183.8% |
| EPS (Diluted) | $17.39 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $940.7M | +141.4% |
| Short-term Investments | $31K | -99.6% |
| Accounts Receivable | $391.7M | +1.0% |
| Inventory | $94.8M | -27.1% |
| Current Assets | $1.55B | +55.2% |
| Total Assets | $4.79B | +6.3% |
| Current Liabilities | $993.0M | +73.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $693.3M | +19.2% |
| Capital Expenditures | $715.9M | +26.1% |
| Investing Cash Flow | $97.1M | +117.5% |
| Financing Cash Flow | -$566.8M | +14.4% |
| Free Cash Flow | -$22.7M | -267.9% |
| +177.7% |
| Long-term Debt |
| $2.12B |
| -15.5% |
| Total Liabilities | $3.35B | +1.6% |
| Stockholders' Equity | $590.7M | +337.6% |